Effects ofCYP2C19 Polymorphisms on Risk of Cardiovascular Events in Chinese Stroke Survivors Receivi

来源 :第9届国际脑血管病高峰论坛 | 被引量 : 0次 | 上传用户:xiaoguang0623
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective: Polymorphisms of CYP2C 19 have been associated with variant risk of subsequent cardiovascular events in survivors of myocardial infarction (MI) receivingclopidogrel.Such an association has not been established in stroke survivors.
其他文献
Objective: Cerebral vasomotor reactivity(CVR) measurements are believed to be a helpful tool for selecting patients who are at higher risk for hemodynamic strokes.
Objective: Ischemic stroke is one of the leading causes of death and disability worldwide.In past decades, researchers have studied the physiopathology and biochemistry of ischemic stroke, but knowled
被忽略的往往是最熟悉的!低血糖的重要性被低估1.发病率高2.全因死亡升高、心、脑、肾、眼多器官损害3.负面情绪4.研究较少,治疗简单化,无靶官保护措施主要内容1 低血糖的概念、危害2 低血糖的临床表现3 低血糖性脑损伤4 低血糖的治疗及葡萄糖再灌注性脑损伤
会议
Objective: To investigate whether ABCD and ABCD2 score can be used to predict craniocervical anterior or posterior circulation artery stenosis in patients with TIA.
一、前言脑血管畸形包括动静脉畸形(AVMs)、海绵状血管畸形(CCMs)、颅内发育性静脉异常(DVAs)、硬脑膜动静脉瘘(DAVFs)、脑毛细血管扩张症(BCTs)DVAs是最常见的脑血管畸形,经尸检/MRI证实的发病率高达2.5-3%DVAs本身可引起各种症状,但症状较轻,一般认为DVAs经过良性,缺乏足够关注
会议
一、背景颅内静脉窦血栓形成(Cerebral Venous Sinus thrombosis,CVST)是一种特殊的脑血管病,占全部脑血管病的3.5%,而死亡率达20%~78%.最早于1825年由Redis报道.
会议
2010年非心源性栓塞的缺血性卒中或TIA抗血小板治疗推存一览(AHA/ASA)推荐意见推荐级别:证据水平对于非心源性栓塞的缺血性卒中或TIA患者,抗血小板治疗降低卒中复发及其他心血管事件的作用优于口服抗凝治疗
会议
中国缺血性卒中亚型CISS分型不稳定定义,随着医学诊断手段的更新和人们对卒中研究的深入而变化隐原性脑卒中(cryptogenic stroke,cs)隐源性脑卒中(CS)的诊断---从常见高危因素和病因的漏诊开始!10%的中国人具有夜间高血压…卒中急性期的血脂低估现象..吸烟的普遍性(女性,未成年人)..激发因素(如感染)的普遍性..阵发性房颤的漏诊..儿童期就开始出现的粥样硬化斑块..
会议
CISS隐源性脑卒中(cryptogenic stroke,CS)隐源性脑卒中(CS)的诊断——从常见高危因素和病因的漏诊开始!10%的中国人具有夜间高血压…卒中急性期的血脂低估现象..吸烟的普遍性(女性,未成年人)..激发困素(如感染)的普遍性..阵发性房颤的漏诊..儿童期就开始出现的粥样硬化斑块..
会议
Rationale: MicroRNAs are released by cultured cells and can be detected in the blood.Recent studies reported that circulating microRNAs profile could be the biomarker of coronary artery disease.